Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Identify leverage points where non-pharmacological interventions can enhance real-world benefit
Most patients experience fewer gastrointestinal issues after 46 weeks as their bodies adapt to semaglutide dosing
Reconstitution and Aliquoting Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage
Longer term For ongoing use, review metabolic and kidney trends every 3-6 months with a clinician
Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Xultophy Patients nave to basal insulin or a GLP-1 agonist: starting dose is 10 units once daily Patients currently on basal insulin or a GLP-1 agonist: starting dose is 16 units once daily Maintenance: titrate dose up or down by 2 units once or twice weekly, depending on blood sugar goals Missed doses: resume dosing at the next scheduled dose
US$ 27.62
US$ 29.05
US$ 28.41
US$ 20.96
US$ 23.18
US$ 22.72
